Dietary factors and diabetes-related health outcomes in patients with type 2 diabetes: protocol for a systematic review and meta-analysis of prospective observational studies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
11 07 2019
Historique:
entrez: 14 7 2019
pubmed: 14 7 2019
medline: 7 7 2020
Statut: epublish

Résumé

Type 2 diabetes (T2D) is a major health concern associated with several comorbidities such as diabetic chronic kidney disease, neuropathy and cardiovascular diseases. Many of these complications may be preventable by an adequate lifestyle, including a favourable dietary behaviour, additionally to pharmacological management. In general, dietary guidelines for patients with diabetes recommend a hypocaloric diet to achieve a normal weight, but there is a lack of detailed instructions on specific nutrients and foods to prevent diabetes-related outcomes. Therefore, the aim of this systematic review and meta-analysis is to summarise the available evidence on the association between dietary factors and health-related outcomes in patients with T2D. A systematic literature search will be conducted in PubMed and Web of Science in May 2019 to identify prospective observational studies investigating dietary factors in association with major complications in patients with T2D. We will include studies investigating dietary patterns, food groups, foods, macronutrients and micronutrients as well as secondary plant compounds. As diabetes-related outcomes, we will include macrovascular (cardiovascular and cerebrovascular diseases) and microvascular outcomes (nephropathy, neuropathy and retinopathy), as well as cancer, quality of life, depression, cognitive disorders and mortality. We will conduct dose-response meta-analyses using random effects models. We will investigate heterogeneity across studies and publication bias. To assess the risk of bias and quality of the included studies, we will use the Cochrane risk of bias tool ROBINS-I and the quality of evidence will be assessed using Grades of Recommendation, Assessment, Development, and Evaluation. As the systematic review is based on published studies, ethical considerations are not required. The systematic review and meta-analysis will be published in a peer-reviewed Journal. CRD42018110669.

Identifiants

pubmed: 31300497
pii: bmjopen-2018-027298
doi: 10.1136/bmjopen-2018-027298
pmc: PMC6629404
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027298

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 1995 Dec 2;311(7018):1457-60
pubmed: 8520331
J Clin Epidemiol. 2019 Jul;111:105-114
pubmed: 29432858
Lancet. 2014 Jun 7;383(9933):1999-2007
pubmed: 24910231
Diabet Med. 2018 May;35(5):541-547
pubmed: 29443421
J Am Diet Assoc. 1995 Oct;95(10):1103-8
pubmed: 7560680
Am J Epidemiol. 2012 Jan 1;175(1):66-73
pubmed: 22135359
Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36
pubmed: 20391306
BMJ Open. 2016 Jul 12;6(7):e010247
pubmed: 27406637
Ophthalmology. 2010 Jan;117(1):71-8
pubmed: 19900709
Ann Oncol. 2012 Apr;23(4):843-52
pubmed: 21890910
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
PLoS One. 2018 Jan 11;13(1):e0186582
pubmed: 29324740
Eur J Epidemiol. 2018 Feb;33(2):141-156
pubmed: 29204902
Nutrients. 2017 Feb 06;9(2):
pubmed: 28178180
J Acad Nutr Diet. 2013 Apr;113(4):569-80
pubmed: 23415502
Diabetes Care. 2018 Jan;41(Suppl 1):S51-S54
pubmed: 29222376
J Clin Endocrinol Metab. 2014 Oct;99(10):3635-43
pubmed: 25050990
PLoS One. 2018 Mar 20;13(3):e0194127
pubmed: 29558518
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
N Engl J Med. 1997 Apr 17;336(16):1117-24
pubmed: 9099655
Am J Epidemiol. 1992 Jun 1;135(11):1301-9
pubmed: 1626547
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Res Synth Methods. 2017 Mar;8(1):5-18
pubmed: 28058794
Epidemiology. 2013 Mar;24(2):204-11
pubmed: 23348071
Diabetes Care. 2018 Jan;41(Suppl 1):S38-S50
pubmed: 29222375

Auteurs

Janett Barbaresko (J)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Manuela Neuenschwander (M)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Lukas Schwingshackl (L)

Institute for Evidence in Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Sabrina Schlesinger (S)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH